The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein–1 in patients with type 2 diabetes complicated by hyperlipidemia

Autor: Takebayashi, Kohzo, Matsumoto, Sachiko, Wakabayashi, Sadao, Inukai, Yoshihisa, Matsutomo, Rika, Aso, Yoshimasa, Inukai, Toshihiko

Publikováno v: In Metabolism 2005 54(9):1225-1229

Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.

Autor: Aso Y, Wakabayashi S, Yamamoto R, Matsutomo R, Takebayashi K, Inukai T, Aso, Yoshimasa, Wakabayashi, Sadao, Yamamoto, Ruriko, Matsutomo, Rika, Takebayashi, Kohzo, Inukai, Toshihiko

Publikováno v: Diabetes Care; Sep2005, Vol. 28 Issue 9, p2211-2216, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia

Autor: Aso, Yoshimasa yaso@dokkyomed.ac.jp, Yoshida, Noboru¹, Okumura, Ki-ichi¹, Wakabayashi, Sadao¹, Matsutomo, Rika¹, Takebayashi, Kohzo¹, Inukai, Toshihiko¹

Publikováno v: Clinica Chimica Acta. Oct2004, Vol. 348 Issue 1/2, p139-145. 7p.

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.

Autor: Inukai T; Department of Internal Medicine, Koshigaya Hospital, Dokkyo University School of Medicine, Saitama, Japan. t-inukai@dokkyomed.ac.jp, Yoshida N, Wakabayashi S, Inukai Y, Matsutomo R, Takanashi K, Nakamachi T, Takebayashi K, Aso Y, Takahashi K

Publikováno v: The American journal of the medical sciences [Am J Med Sci] 2005 May; Vol. 329 (5), pp. 222-7.